Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Clin Nucl Med ; 47(1): 76-78, 2022 Jan 01.
Article in English | MEDLINE | ID: mdl-34238798

ABSTRACT

ABSTRACT: A 61-year-old man after resection of well-differentiated midgut neuroendocrine neoplasia (NEN) was referred to 18F-fluorodihydroxyphenylalanine PET/CT for localization of recurrent midgut NEN in the context of clinical symptoms and mild elevation of serum CgA (chromogranin A) levels. Isolated hepatic focus of increased 18F-Fluorodihydroxyphenylalanine uptake was detected. The biopsy of this focus, followed by radiofrequency ablation, revealed a hepatic cavernous hemangioma. Complete remission of midgut NEN was confirmed during 4-year clinical and imaging follow-up. The persistent mild elevation of serum CgA was retrospectively attributed to treatment with proton-pump inhibitors.


Subject(s)
Hemangioma, Cavernous , Neuroendocrine Tumors , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Positron Emission Tomography Computed Tomography , Retrospective Studies
2.
Plants (Basel) ; 10(11)2021 Oct 30.
Article in English | MEDLINE | ID: mdl-34834717

ABSTRACT

Changes in the distribution of annual rainfall totals, together with the increase in temperature over the last 40 years, are causing more frequent periods of drought, and plants are more often exposed to water stress. The aim of this study was to monitor the effect of different water regimes (irrigated and non-irrigated) of individuals of walnut tree (Juglans regia L.) in a private orchard located in the West of Slovakia. Our research was focused on dendrometric and sap flow measurements in the period from 28 March to 2 June 2019. The results showed differences in the sap flow of walnut trees during the budbreak period: when trees were irrigated, sap flow in the diurnal cycle was around 130 g·h-1 (20.48%), higher than in the non-irrigated treatment. Dendrometric differences between the irrigated and non-irrigated treatments were not significant. The sap flow data in the flowering period of the irrigated variant were slightly higher at 150 g·h-1 (35.62%) than non-irrigated. Dendrometric differences were more significant when the difference between the variants was more than 1.5 mm. Continuation of this research and analysis of the data obtained in the coming years will allow us to evaluate the effects of the environment on fruit trees in the long term.

3.
Vnitr Lek ; 65(4): 326, 2019.
Article in English | MEDLINE | ID: mdl-31091955

ABSTRACT

Extremitovascular arterial ischemic disease (lower extremity peripheral arterial disease - PAD) is an important manifestation of systemic atherosclerosis and other arterial diseases of vascular system. The lower the ankle-brachial pressure index, the greater the risk of serious acute instable organovascular events (e. g. acute myocardial infarction, stroke). Complex prevention and treatment of extremitovascular arterial disease is discussed in this article. Angiology/vascular medicine is the fastest growing field of internal medicine.


Subject(s)
Atherosclerosis , Diabetes Complications , Diabetes Mellitus , Peripheral Arterial Disease , Ankle Brachial Index , Humans , Lower Extremity , Peripheral Arterial Disease/therapy , Risk Factors
4.
Vnitr Lek ; 61 Suppl 5: 12-20, 2015.
Article in Czech | MEDLINE | ID: mdl-26800468

ABSTRACT

UNLABELLED: Neuroendocrine neoplasmas are a form of cancer arising from cells of diffuse neuroendocrine system. They produce peptides or amines that act as hormones or neurotransmitters. Incidence of NENs is relatively low. Diagnostic work-up and treatment requires a multidisciplinary team approach. The aim of this study was an analysis of data from patients with well-differentiated neuroendocrine neoplasmas of gastrointestinal tract. The study included patients followed up from 1998 to 2013 with histologically confirmed well-differentiated digestive neuroendocrine neoplasm with low or intermediate malignant potential. 97 patients were included; 34 men (35.1 %) and 63 women (64.9 %). In patients being diagnosed after 2005 interferon treatment is significantly less used than endoscopic and peptide receptor radionuclide therapy. We have identified more appropriate discriminant values of 5-HIAA and chromogranin A (6.8 mg/24 hours; 70 ng/ml) for predicting the presence of metastases at the time of diagnosis. We have identified following risk factors for overall mortality: liver metastases, presence of diarrhea, flush, small bowel primary tumor, high values of CgA and 5-HIAA at the time of diagnosis (5-HIAA > 520.52 mg/24 hours, CgA > 174.5 ng/ml). Surgical treatment was found to be a positive prognostic factor. KEY WORDS: chromogranin A - 5-hydroxyindoleacetic acid - neuroendocrine neoplasm.

5.
Vnitr Lek ; 61(12 Suppl 5): 5S12-20, 2015 Dec.
Article in Slovak | MEDLINE | ID: mdl-27124967

ABSTRACT

Neuroendocrine neoplasmas are a form of cancer arising from cells of diffuse neuroendocrine system. They produce peptides or amines that act as hormones or neurotransmitters. Incidence of NENs is relatively low. Diagnostic work-up and treatment requires a multidisciplinary team approach. The aim of this study was an analysis of data from patients with well-differentiated neuroendocrine neoplasmas of gastrointestinal tract. The study included patients followed up from 1998 to 2013 with histologically confirmed well-differentiated digestive neuroendocrine neoplasm with low or intermediate malignant potential. 97 patients were included; 34 men (35.1%) and 63 women (64.9%). In patients being diagnosed after 2005 interferon treatment is significantly less used than endoscopic and peptide receptor radionuclide therapy. We have identified more appropriate discriminant values of 5-HIAA and chromogranin A (6.8 mg/24 hours; 70 ng/ml) for predicting the presence of metastases at the time of diagnosis. We have identified following risk factors for overall mortality: liver metastases, presence of diarrhea, flush, small bowel primary tumor, high values of CgA and 5-HIAA at the time of diagnosis (5-HIAA > 520.52 mg/24 hours, CgA > 174.5 ng/ml). Surgical treatment was found to be a positive prognostic factor.


Subject(s)
Antineoplastic Agents/therapeutic use , Biomarkers, Tumor/blood , Endoscopy, Digestive System , Gastrointestinal Neoplasms/therapy , Interferons/therapeutic use , Intestine, Small/surgery , Liver Neoplasms/secondary , Neuroendocrine Tumors/therapy , Radiotherapy/methods , Adult , Chromogranin A/blood , Female , Gastrointestinal Neoplasms/blood , Gastrointestinal Neoplasms/pathology , Humans , Hydroxyindoleacetic Acid/blood , Intestine, Small/pathology , Male , Middle Aged , Neuroendocrine Tumors/blood , Neuroendocrine Tumors/pathology , Prognosis
6.
Vnitr Lek ; 60(3): 239-48, 2014 Mar.
Article in Czech | MEDLINE | ID: mdl-24981699

ABSTRACT

Organovascular arterial ischemic diseases (cardiovascular, cerebrovascular, extremitovascular, renovascular, genitovascular, pulmovascular, mesenterovascular, dermovascular, oculovascular, otovascular, stomatovascular etc.) are an important manifestations of systemic atherosclerosis and other arterial diseases of vascular system (arteriolosclerosis/arteriolonecrosis; diabetic macroangiopathy; diabetic microangiopathy; Mönckeberg´s mediosclerosis/mediocalcinosis; arteritis - vasculitis; syndromes of arterial compression; fibromuscular dysplasia; cystic adventitial degeneration; arterial thrombosis; arterial embolism/thromboembolism; traumatic and posttraumatic arteriopathies; physical arteriopathies; chemical and toxic arteriopathies; iatrogenic arterial occlusions; dissection of aorta and of arteries; coiling; kinking; complicated arterial aneurysms; arteriovenous fistula, rare vascular diseases). Key clinical-etiology-anatomy-pathophysiology (CEAP) aspects of the mesenteriovascular arterial ischemic diseases are discussed in this article (project Vessels).


Subject(s)
Arterial Occlusive Diseases/classification , Arterial Occlusive Diseases/prevention & control , Arterial Occlusive Diseases/diagnosis , Humans , Slovakia
7.
Endocr Pract ; 20(8): e140-4, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24793921

ABSTRACT

OBJECTIVE: We report the presentation and novel therapy of a calcitonin-secreting pancreatic neuroendocrine tumor (PNET) and review the literature on this unusual neoplasm. METHODS: We cite the history of a 38-year-old male who presented with fatigue, weight loss, and diarrhea and was found to have a pancreatic head mass on cross-sectional imaging, as well as liver metastases. RESULTS: The patient's laboratory evaluation was notable for a >100-fold elevation of the peptide hormone calcitonin in serum. As calcitonin is typically secreted by thyroid C-cells, hypercalcitoninemia is considered a marker for medullary thyroid cancer (MTC) or C-cell hyperplasia, but it may be present in several physiologic or pathologic conditions or may be ectopically secreted in rare PNETs. An octreotide scan confirmed the presence of somatostatin (SST) receptors on the pancreatic mass and liver metastases, leading to the diagnosis of a calcitonin-secreting PNET. We initiated treatment with long-acting SST analogs and peptide receptor radionuclide therapy (90Yttrium-DOTATOC) and achieved disease regression while maintaining a high quality of life. CONCLUSION: Functional PNETs that secrete calcitonin are exceedingly rare, but they are important to consider in the differential diagnosis of nonthyroid-mediated hypercalcitonemia or pancreatic tumors that present with diarrhea, as the management differs markedly from both MTC and other pancreatic malignancies.

SELECTION OF CITATIONS
SEARCH DETAIL
...